Allisone Review

What It Is

Allisone is a French AI startup that analyzes dental X-rays to help dentists explain diagnoses to patients. Upload a panoramic or periapical radiograph, and Allisone's deep learning model highlights pathologies with color-coded overlays -- cavities in one color, bone loss in another, existing restorations in a third. It then generates automated reports and treatment plan suggestions based on what it finds.

The core value proposition is patient communication, not diagnosis replacement. When patients can see their cavity highlighted in red on their own X-ray, they're reportedly twice as likely to accept treatment. Allisone turns the "trust me, you need a crown" conversation into a visual, evidence-based discussion.

Nearly 10,000 dental professionals in Europe use the platform, primarily in France where the company is headquartered.

Who It's For

Allisone is built for European dental practices -- particularly French ones -- that want AI assistance with X-ray interpretation and patient education. It's best suited for:

• General dentists who want a second opinion on radiographic findings
• Practices struggling with treatment acceptance rates
• Dentists who want to spend less time explaining X-rays and more time treating
• Offices looking to standardize diagnostic documentation

If you're a US-based practice, Allisone is not the right fit right now. It lacks FDA clearance, and US competitors like Pearl AI, Overjet, and VideaHealth are FDA-cleared and better integrated with American PMS platforms.

Key Features

AI X-Ray Analysis: Deep learning model interprets 2D dental X-rays (panoramic and retroalveolar), detecting pathological and non-pathological elements including caries, periapical lesions, bone loss, existing restorations, and anatomical structures.

Color-Coded Visual Overlays: Each finding type gets a distinct color on the X-ray image, making it immediately understandable for patients. This is the feature that drives treatment acceptance.

Spotimplant AI: Patented technology that identifies over 500 dental implant types from X-rays -- useful for cases where patients don't know what implant system they have.

Automated Reports: Generates radiology reports and post-consultation summaries with tooth numbering, legends, and care recommendations. Saves significant documentation time.

Treatment Plan Generation: Suggests treatment plans based on detected findings and dentist preferences. Supports voice-assisted dictation for efficiency.

Patient Records: Unified storage for all patient X-rays with automatic uploads and API integrations to practice management and imaging software.

Pricing

Allisone does not publish pricing. You'll need to request a demo for a custom quote. Given it's a European B2B SaaS product targeting dental offices, expect subscription pricing scaled to practice size.

Pros

• Color-coded X-ray overlays are genuinely effective for patient education
• Implant identification (500+ types) solves a real clinical headache
• Automated reporting saves documentation time
• Standardizes diagnostic workflow across a practice
• Strong patient communication tools boost treatment acceptance
• Growing user base (10,000+ professionals) validates the concept

Cons

• Not FDA-cleared -- not available for US practices
• Limited to 2D X-rays (no CBCT or 3D analysis)
• No public pricing
• Primarily French/European market with limited English-language resources
• Sparse user reviews make independent evaluation difficult
• Competitors like Pearl AI and Overjet offer broader US regulatory approval and integration
• AI acts as "second opinion" only -- still requires full clinical verification

The Bottom Line

Allisone is a smart, well-designed AI tool for patient communication around dental X-rays. The color-coded overlays genuinely help patients understand what they're looking at, and the implant identification feature solves a problem every dentist has encountered. For European practices, it's worth evaluating alongside competitors.

But for the US market -- which is what most of our readers care about -- Allisone isn't ready. No FDA clearance, limited US integrations, and stronger domestic alternatives (Pearl AI for broad pathology detection, Overjet for insurance workflow integration, VideaHealth for comprehensive diagnostics) mean American practices should look elsewhere.

We'll revisit this rating if and when Allisone enters the US market with FDA clearance. For now, it's a promising European player that isn't relevant to most of our audience.